A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction
Fertility and sterility, 75(5), 1024-1026
Abstract
To compare the rates of ovulation and pregnancy after tamoxifen citrate (TMX) or clomiphene citrate (CC) among anovulatory women with infertility.
Prospective randomized trial.
Infertility clinic in a university teaching hospital. PATIENT(S): Eighty-six anovulatory women under 40 years of age undergoing ovulation induction. INTERVENTION(S): The women were assigned randomly to receive either TMX or CC on cycle days 5-9. MAIN OUTCOME MEASURE(S): Rates of ovulation and pregnancy for the two treatment modalities. RESULTS(S): The overall rate of ovulation in the TMX group was 50 of 113 (44.2%) and in the CC group, 41 of 91 (45.1%). There were 10 pregnancies in the TMX group and 6 pregnancies in the CC group. The cycle fecundity per ovulatory cycle was 20.0% in the TMX group and 14.6% in the CC group. CONCLUSION(S): The overall rate of ovulation and pregnancy were similar with TMX and CC. TMX is a suitable alternative agent to CC in the management of anovulatory infertility.
Topics
Cite this article
Boostanfar, R., Jain, J. K., Mishell DR Jr, & Paulson, R. J. (2001). A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. *Fertility and sterility*, *75*(5), 1024-1026. https://doi.org/10.1016/s0015-0282(01)01749-6
Boostanfar R, Jain JK, Mishell DR Jr, Paulson RJ. A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. Fertil Steril. 2001;75(5):1024-1026. doi:10.1016/s0015-0282(01)01749-6
Boostanfar, R., et al. "A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction." *Fertility and sterility*, vol. 75, no. 5, 2001, pp. 1024-1026.
Keywords
Adult, Clomiphene, Female, Humans, Infertility, Luteinizing Hormone, Male, Ovulation Induction, Pregnancy, Pregnancy Rate, Prospective Studies, Selective Estrogen Receptor Modulators, Tamoxifen